Transitional cell carcinoma MRI: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==MRI== | ==MRI== | ||
MRI may be helpful in the diagnosis of transitional cell carcinoma of renal pelvis. Findings on MRI diagnostic of transitional cell carcinoma include: | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | ||
Line 50: | Line 41: | ||
Enhancement | Enhancement | ||
|} | |} | ||
===Transitional cell carcinoma of bladder=== | |||
* MRI is superior to other modalities in locally staging the [[tumor]] and is in some instances able to distinguish T1 from T2 tumors on T2 weighted image.<ref name=radiopaedia>Transitional cell carcinoma of the bladder. Dr Ian Bickle and Dr Frank Gaillard et al. Radiopaedia.org 2015.http://radiopaedia.org/articles/transitional-cell-carcinoma-of-the-bladder Accessed on February, 18 2015</ref> | |||
:* T1: isointense compared to [[muscle]] | |||
:* T2: slightly hyperintense compared to muscle | |||
:* T1 weighted image with gadolinium contrast: demonstrates enhancement | |||
===Transitional cell carcinoma of the renal pelvis=== | |||
*Transitional cell carcinomas are isointense to renal parenchyma on both T1 and T2 weighted images. Following administration of Gadolinium, TCCs enhance but less so than normal renal parenchyma. | |||
*T1 : Isointense to renal parenchyma | |||
*Moderate enhancement on gadolinium | |||
==References== | ==References== |
Revision as of 21:44, 18 February 2016
Transitional cell carcinoma Microchapters |
Differentiating Transitional cell carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transitional cell carcinoma MRI On the Web |
American Roentgen Ray Society Images of Transitional cell carcinoma MRI |
Directions to Hospitals Treating Transitional cell carcinoma |
Risk calculators and risk factors for Transitional cell carcinoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
MRI
MRI may be helpful in the diagnosis of transitional cell carcinoma of renal pelvis. Findings on MRI diagnostic of transitional cell carcinoma include:
Signal | Renal Pelvis | Ureter | Urinary Bladder |
---|---|---|---|
T1 Signal |
Isointense to renal parenchyma |
Isointense to muscle |
Isointense to muscle |
T2 Signal |
Isointense to renal parenchyma |
Slightly hyperintense to muscle |
Slightly hyperintense to muscle |
T1 C+ (Gd): |
Moderate enhancement |
Enhancement |
Enhancement |
Transitional cell carcinoma of bladder
- MRI is superior to other modalities in locally staging the tumor and is in some instances able to distinguish T1 from T2 tumors on T2 weighted image.[1]
- T1: isointense compared to muscle
- T2: slightly hyperintense compared to muscle
- T1 weighted image with gadolinium contrast: demonstrates enhancement
Transitional cell carcinoma of the renal pelvis
- Transitional cell carcinomas are isointense to renal parenchyma on both T1 and T2 weighted images. Following administration of Gadolinium, TCCs enhance but less so than normal renal parenchyma.
- T1 : Isointense to renal parenchyma
- Moderate enhancement on gadolinium
References
- ↑ Transitional cell carcinoma of the bladder. Dr Ian Bickle and Dr Frank Gaillard et al. Radiopaedia.org 2015.http://radiopaedia.org/articles/transitional-cell-carcinoma-of-the-bladder Accessed on February, 18 2015